Home » Stocks » AVGR

Avinger, Inc. (AVGR)

Stock Price: $2.09 USD -0.21 (-9.13%)
Updated Jan 21, 2021 4:00 PM EST - Market closed
After-hours: $2.12 +0.03 (1.44%) Jan 21, 7:58 PM
Market Cap 179.28M
Revenue (ttm) 8.59M
Net Income (ttm) -23.29M
Shares Out 69.46M
EPS (ttm) -0.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 21
Last Price $2.09
Previous Close $2.30
Change ($) -0.21
Change (%) -9.13%
Day's Open 2.16
Day's Range 2.05 - 2.21
Day's Volume 17,094,608
52-Week Range 0.22 - 2.30

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Accesswire - 2 days ago

19 New U.S. and International Patents Issued and Allowed in 2020 REDWOOD CITY, CA / ACCESSWIRE / January 19, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marke...

InvestorPlace - 6 days ago

Avinger (AVGR) stock is taking off on Friday after announcing the full commercial release of its Tigereye medical device. The post AVGR Stock: 11 Things to Know About Avinger as Shares Rocket ...

Accesswire - 6 days ago

REDWOOD CITY, CA / ACCESSWIRE / January 15, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-base...

InvestorPlace - 1 week ago

Avinger (AVGR) is seeing a massive boost to its stock on Friday after being listed as a hot penny stock to buy on Robinhood. The post AVGR Stock: 6 Things to Know About ‘Robinhood's Hot Penny ...

Accesswire - 2 weeks ago

REDWOOD CITY, CA / ACCESSWIRE / January 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the di...

Accesswire - 4 weeks ago

REDWOOD CITY, CA / ACCESSWIRE / December 23, 2020 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the ...

Seeking Alpha - 2 months ago

Avinger's (AVGR) CEO Jeff Soinski on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Avinger (AVGR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Investment Research - 4 months ago

Avinger (AVGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

InvestorPlace - 4 months ago

Avinger (AVGR) news for Friday concerning approval from the FDA for one of its medical devices has AVGR stock on the move. The post Avinger News: AVGR Stock Down 8% Following FDA Approval appe...

Seeking Alpha - 5 months ago

Avinger's (AVGR) CEO Jeff Soinski on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 6 months ago

Inside the top-ranked stocks that have been exhibiting rising price-to-earnings ratios.

Other stocks mentioned: BLRX, PTI, VCNX, VIVE
Zacks Investment Research - 7 months ago

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Other stocks mentioned: CSV, MOGO, PTE, TNK
Forbes - 7 months ago

There are pockets of the stock market that look far too overvalued to ignore, and our deep learning algorithms paired with our Artificial Intelligence (“AI”) technology has identified the top ...

Other stocks mentioned: GHSI, KAR
Zacks Investment Research - 7 months ago

Avinger (AVGR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Seeking Alpha - 8 months ago

Avinger, Inc. (AVGR) CEO Jeff Soinski on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Forget undervalued stocks, play these top-ranked stocks with rising P/E.

Other stocks mentioned: FEYE, JAKK, PTI, WATT
Zacks Investment Research - 8 months ago

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Other stocks mentioned: ACRX, GNCA, GOSS, VFF
Zacks Investment Research - 1 year ago

Bet on these top-ranked stocks with rising P/E for outsized gains.

Other stocks mentioned: ALXN, CYBR, ONVO, QLYS
Seeking Alpha - 1 year ago

Avinger, Inc. (AVGR) CEO Jeffrey Soinski on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Other stocks mentioned: ALXN, CHKP, NOW, TRIP
Zacks Investment Research - 1 year ago

Avinger (AVGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Investment Research - 1 year ago

Top Ranked Momentum Stocks to Buy for October 24th

Other stocks mentioned: ACM, BC, BOOT
Zacks Investment Research - 1 year ago

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

Other stocks mentioned: SPSC, SWKS, TUES, VAR
GlobeNewsWire - 1 year ago

REDWOOD CITY, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD) today announced the clo...

GlobeNewsWire - 1 year ago

REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced the pr...

GlobeNewsWire - 1 year ago

REDWOOD CITY, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced that i...

Seeking Alpha - 1 year ago

Avinger's (AVGR) CEO Jeff Soinski on Q2 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Is (AVGR) Outperforming Other Medical Stocks This Year?

Seeking Alpha - 1 year ago

Avinger, Inc. (AVGR) CEO Jeff Soinski on Q1 2019 Results - Earnings Call Transcript

Zacks Investment Research - 1 year ago

Is (AVGR) Outperforming Other Medical Stocks This Year?

Zacks Investment Research - 1 year ago

Avinger (AVGR) closed at $0.58 in the latest trading session, marking a -0.62% move from the prior day.

Zacks Investment Research - 1 year ago

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, April 9th.

Other stocks mentioned: ADP, CMG

About AVGR

Avinger, a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family o... [Read more...]

Industry
Medical Devices
IPO Date
Jan 30, 2015
CEO
Jeffrey Soinski
Employees
74
Stock Exchange
NASDAQ
Ticker Symbol
AVGR
Full Company Profile

Financial Performance

In 2019, Avinger's revenue was $9.13 million, an increase of 15.36% compared to the previous year's $7.92 million. Losses were -$19.45 million, -29.42% less than in 2018.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for Avinger stock is "Buy." The 12-month stock price forecast is 2.50, which is an increase of 19.62% from the latest price.

Price Target
$2.50
(19.62% upside)
Analyst Consensus: Buy